Breakthrough Multi-Targeted Drug Candidates Puts Axcella at Forefront of Liver Disease Treatment Market
Image Provided By Unsplash
Axcella Highlights Publication In The American Journal Of Gastroenterology Of Results From AXA1125-003 In Subjects With Presumed NASH
AXA1125 demonstrates meaningful reductions in key measures of liver metabolism, inflammation, and fibrosis
Axcella (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex
JP Morgan Downgrades Axcella Health to Underweight
JP Morgan analyst Jessica Fye downgrades Axcella Health (NASDAQ:AXLA) from Neutral to Underweight.
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
61 Biggest Movers From Yesterday
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday.
42 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) jumped 79% to $48.70 after jumping around 42% on Tuesday.
61 Biggest Movers From Yesterday
Gainers
BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday.
42 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47.
BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday.